Figure 2From: Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?The three trials in which patients receiving coronary stents were randomized to receive one or another dosing regimen of ticlopidine or clopidogrel. NS, not significant; MACE, major adverse cardiac events.Back to article page